Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04006184 · ClinicalTrials.gov registry record

Retrospective Review of Saphenous Vein Incompetence: Venaseal Versus Endovenous Thermal Ablation

A clinical trial of Venous Insufficiency and Varicose Veins, sponsored by Lake Washington Vascular.

Completed
Registry status
547
Enrollment target
1
Study location

NCT04006184 is a study of Venous Insufficiency and Varicose Veins that has completed, run by Lake Washington Vascular. The registered enrollment target is 547 participants, above the 91-participant average among 9 other Venous Insufficiency trials with a reported enrollment target (501% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04006184, a study of Venous Insufficiency and Varicose Veins, has completed, sponsored by Lake Washington Vascular.

COMPLETED
Registry status
547 participants
Enrollment target
1
Study location

Study Summary

This study is a retrospective, chart review of treatment of patients with symptomatic varicose veins. Treated limbs must have the Great Saphenous Vein and/or Small Saphenous Vein treated with either cyanoacrylate closure (VenaSeal) or Endothermal Ablation (either Radiofrequency Ablation or Endovenous Laser Ablation).

Interventions

  • OTHER Chart review

Study Locations (1)

Washington

  • Lake Washington Vascular, PLLC - Bellevue

Trial Details

FieldValue
Enrollment Target 547 participants
Start Date 2019-06-14
Est. Completion 2019-08-30

Sponsor

Lake Washington Vascular

2 total trials

What the Registry Record Tells You About NCT04006184

The ClinicalTrials.gov registry entry for NCT04006184 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 547 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 91-participant average among 9 other Venous Insufficiency trials with a reported enrollment target (501% higher). The listed sponsor is Lake Washington Vascular, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Venous Insufficiency appearing as the primary indexed condition, and to 1 intervention - of which Chart review is the first listed.

NCT04006184 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT04006184 about?

NCT04006184 is a clinical study titled "Retrospective Review of Saphenous Vein Incompetence: Venaseal Versus Endovenous Thermal Ablation". This study is a retrospective, chart review of treatment of patients with symptomatic varicose veins. Treated limbs must have the Great Saphenous Vein and/or Small Saphenous Vein treated with either cyanoacrylate closure (VenaSeal) or Endothermal Ablation (either Radiofrequency Ablation or Endovenou...

What is the current status of trial NCT04006184?

This trial is currently completed. The enrollment target is 547 participants. The study started on 2019-06-14. Estimated completion is 2019-08-30.

What conditions does trial NCT04006184 study?

This clinical trial studies the following conditions: Venous Insufficiency, Varicose Veins, Venous Reflux.

What interventions are being tested in trial NCT04006184?

The interventions under investigation include: Chart review (OTHER).

Who is sponsoring clinical trial NCT04006184?

This trial is sponsored by Lake Washington Vascular, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04006184 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Venous Insufficiency

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.